Orthofix Medical Inc.
NASDAQ Global SelectTotal Valuation
Orthofix Medical Inc. carries a market capitalization of 392.90M, placing it among publicly traded companies globally. Its enterprise value stands at 599.92M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 392.90M |
| Enterprise Value | 599.92M |
Share Statistics
Orthofix Medical Inc. currently has 40.38M shares outstanding.
| Shares Outstanding | 40.38M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
The price-to-sales ratio is 0.55, and the price-to-book ratio stands at -1.19.
| PE Ratio | N/A |
| PS Ratio | 0.55 |
| PB Ratio | -1.19 |
| P/TBV Ratio | 2.68 |
| P/FCF Ratio | 13.42 |
| P/OCF Ratio | 13.42 |
Enterprise Valuation
On an enterprise value basis, Orthofix Medical Inc. trades at an EV/EBITDA multiple of 39.07 and an EV/FCF ratio of 11.33.
| EV / Sales | 0.73 |
| EV / EBITDA | 39.07 |
| EV / EBIT | N/A |
| EV / FCF | 11.33 |
Financial Position
Orthofix Medical Inc. maintains a current ratio of 2.87, meaning it holds 2.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 60.26, indicating elevated leverage, while an interest coverage ratio of 0.82 demonstrates limited ability to service its debt obligations.
| Current Ratio | 2.87 |
| Quick Ratio | 1.60 |
| Debt / Equity | 60.26 |
| Debt / EBITDA | 17.08 |
| Interest Coverage | 0.82 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -7.02 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 1.37 |
Taxes
| Income Tax | 495,000.00 |
| Effective Tax Rate | N/A |
Stock Price Statistics
Orthofix Medical Inc.'s stock has declined approximately -10.82569% over the past 52 weeks. The 50-day moving average sits at 11.69, while the 200-day moving average is 13.77.
| Beta (5Y) | N/A |
| 52-Week Price Change | -10.82569% |
| 50-Day Moving Average | 11.69 |
| 200-Day Moving Average | 13.77 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Orthofix Medical Inc. generated 825.37M in revenue and converted that into -60.01M in net income, yielding earnings per share of -1.50. EBITDA reached 15.35M, while operating income came in at -46.77M.
| Revenue | 825.37M |
| Gross Profit | 583.94M |
| Operating Income | -46.77M |
| Pretax Income | -59.51M |
| Net Income | -60.01M |
| EBITDA | 15.35M |
| EBIT | -46.77M |
| Earnings Per Share (EPS) | -1.50 |
Balance Sheet
Orthofix Medical Inc. holds 120.28M in cash and equivalents against 262.26M in total debt, resulting in a net debt position of 101.06M. Total book value stands at -385.20M, with working capital of 300.49M providing operational flexibility.
| Cash & Cash Equivalents | 120.28M |
| Total Debt | 262.26M |
| Net Debt | 101.06M |
| Equity (Book Value) | -385.20M |
| Book Value Per Share | -9.65 |
| Working Capital | 300.49M |
Cash Flow
Orthofix Medical Inc. produced 34.13M in operating cash flow over the past twelve months.
| Operating Cash Flow | 34.13M |
| Capital Expenditures | N/A |
| Free Cash Flow | 34.13M |
| FCF Per Share | 0.85 |
Margins
Orthofix Medical Inc. operates with a gross margin of 70.75, reflecting its pricing power and cost economics. The operating margin of -5.67 and net profit margin of -7.27 provide insight into operational efficiency.
| Gross Margin | 70.75 |
| Operating Margin | -5.67 |
| Pretax Margin | -7.21 |
| Profit Margin | -7.27 |
| EBITDA Margin | 1.86 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -13.94 |
| FCF Yield | 7.45 |
Scores
Orthofix Medical Inc. posts an Altman Z-Score of 1.39, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 1.39 |